R101933
Term · Oncology and biomedicine · MLC-T-ONC-007130
A substance that is being studied for its ability to make cancer cells respond to drugs to which they have become resistant. It belongs to the family of drugs called multidrug resistance inhibitors.
| Identifier | MLC-T-ONC-007130 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007130",
"term": "R101933",
"field": "Oncology and biomedicine",
"definition": "A substance that is being studied for its ability to make cancer cells respond to drugs to which they have become resistant. It belongs to the family of drugs called multidrug resistance inhibitors.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/r101933/"
}
Record 13,949 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.